Patient Guide: Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 14 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05992935
Status: ACTIVE_NOT_RECRUITING
Condition: Norovirus Acute Gastroenteritis
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 14 locations across the country.

Top locations include:
  • • Long Beach, California
  • • Longmont, Colorado
  • • Hollywood, Florida
  • • And 11 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age - Join Clinical Trial NCTNCT05992935

How to Join This Clinical Trial - NCTNCT05992935

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Norovirus Acute Gastroenteritis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Norovirus Acute Gastroenteritis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Norovirus Acute Gastroenteritis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05992935 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 14 locations. Find a study site near you:

Clinical Research Site

Long Beach, California 90815 - United States

Status: Contact for availability

Clinical Research Site

Longmont, Colorado 80501 - United States

Status: Contact for availability

Clinical Research Site

Hollywood, Florida 33024 - United States

Status: Contact for availability

Clinical Research Site

Decatur, Georgia 30030 - United States

Status: Contact for availability

Clinical Research Site

Meridian, Idaho 83642 - United States

Status: Contact for availability

Clinical Research Site

Peoria, Illinois 61614 - United States

Status: Contact for availability

Clinical Research Site

Sioux City, Iowa 51106 - United States

Status: Contact for availability

Clinical Research Site

Lenexa, Kansas 66219 - United States

Status: Contact for availability

Clinical Research Site

Rockville, Maryland 20854 - United States

Status: Contact for availability

Clinical Research Site

Norfolk, Nebraska 68701 - United States

Status: Contact for availability

And 4 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Norovirus Acute Gastroenteritis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships